Immunor’s vaccine platforms are combining selection and design of antigens fit for immune stimulation combined with adjuvant strategies that allow for the broad and general approach to vaccine development. Traditional vaccines have been using whole dead bacteria, viruses or sub-units as target vaccine antigens. These approaches have over the years been improved, and most technologies…